125 related articles for article (PubMed ID: 17413705)
1. Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
Matthews GV; Dore GJ
AIDS; 2007 Mar; 21(6):777-8. PubMed ID: 17413705
[No Abstract] [Full Text] [Related]
2. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
[TBL] [Abstract][Full Text] [Related]
3. Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
Bani-Sadr F; Palmer P; Scieux C; Molina JM
Clin Infect Dis; 2004 Oct; 39(7):1062-4. PubMed ID: 15472862
[TBL] [Abstract][Full Text] [Related]
4. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment: a tale of two viruses.
Dieterich DT
AIDS Read; 2002 Oct; 12(10):448-9. PubMed ID: 12408102
[No Abstract] [Full Text] [Related]
6. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
7. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
Matthews GV; Cooper DA; Dore GJ
Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
Benhamou Y; Tubiana R; Thibault V
N Engl J Med; 2003 Jan; 348(2):177-8. PubMed ID: 12519935
[No Abstract] [Full Text] [Related]
9. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Van Bömmel F; Schernick A; Hopf U; Berg T
Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
[No Abstract] [Full Text] [Related]
10. Rapid improvement of liver function in a patient with HIV and hepatitis B coinfection treated with lamivudine and tenofovir.
Lehmann C; Wyen C; Fätkenheuer G
Infection; 2006 Aug; 34(4):234-5. PubMed ID: 16896585
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
van Bömmel F; Wünsche T; Schürmann D; Berg T
Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063
[No Abstract] [Full Text] [Related]
12. Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC.
TreatmentUpdate; 2005; 17(5):5-7. PubMed ID: 17225279
[No Abstract] [Full Text] [Related]
13. Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
Jenny-Avital ER
N Engl J Med; 2006 Jun; 354(23):2506-8; author reply 2506-8. PubMed ID: 16764056
[No Abstract] [Full Text] [Related]
14. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Feinberg J
AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
[No Abstract] [Full Text] [Related]
15. Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.
Tamalet C; Tomei C; Henry M; Solas C; Villacian J; Colson P
AIDS; 2007 Nov; 21(18):2551-2. PubMed ID: 18025898
[No Abstract] [Full Text] [Related]
16. Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
Parienti JJ
J Antimicrob Chemother; 2009 May; 63(5):1080; author reply 1080-1. PubMed ID: 19158108
[No Abstract] [Full Text] [Related]
17. Anti-HIV agents. The puzzle of virologic failure with tenofovir.
TreatmentUpdate; 2004; 16(3):4. PubMed ID: 17216834
[No Abstract] [Full Text] [Related]
18. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
Redfield RR; Morrow JS
Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
[No Abstract] [Full Text] [Related]
19. Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.
Landman GW; Soonawala D
Clin Infect Dis; 2010 Apr; 50(8):1200; author reply 1200. PubMed ID: 20233045
[No Abstract] [Full Text] [Related]
20. Tenofovir helpful for patients with HBV.
AIDS Patient Care STDS; 2005 May; 19(5):347. PubMed ID: 15948275
[No Abstract] [Full Text] [Related]
[Next] [New Search]